Published October 1993 | Version v1
Journal article

Efficacy of 3,4,3-LIHOPO for reducing the retention of 238Pu in rat after inhalation of the tributyl phosphate complex

  • 1. CEA, Bruyeres le Chatel (France). DSV/DPTE/LRT
  • 2. Pierre et Marie Curie Univ., Paris (France). Lab. de Chimie des Organoelements
  • 3. Paris Nord Univ. (France). Lab. de Chimie Structurale Biomoleculaire
  • 4. Lawrence Berkeley Lab., CA (United States)

Description

The efficacy of 3,4,3-LIHOPO, a siderophore analogue, has been tested for removing 238Pu from rat after inhalation of plutonium as the tri-N-butylphosphate (TBP) complex. The amounts of Pu retained in the lung of untreated rat, 7 days after exposure ranged from 0.86 to 37 kBq. Results have been compared with DTPA, the current therapy of choice for man. The ligand 3,4,3-LIHOPO was more effective than DTPA for removing Pu from the body when repeated treatment began 1 h after inhalation. This observation was independent of the mass of Pu deposited in the lungs. The efficacy of 3,4,3-LIHOPO was mainly due to the decrease of Pu retention in lung, 1.5 times less than after DTPA administration; in liver and skeleton, retention was about four times less. (Author)

Additional details

Publishing Information

Journal Title
International Journal of Radiation Biology
Journal Volume
64
Journal Issue
4
Journal Page Range
p. 431-436.
ISSN
0955-3002
CODEN
IJRBE7